Elisa Testino

Most-cited papers

1. One year of mepolizumab. Efficacy and safety in real-life in Italy.

   D. Bagnasco, M. Caminati, F. Menzella, M. Milanese +14 more

   2019Pulmonary Pharmacology & Therapeutics69 citations

   Semantic Scholar

   Save

2. Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma

   D. Bagnasco, M. Caminati, Matteo Ferrando, T. Aloè +3 more

   2018BioMed Research International58 citations Open access

   Semantic Scholar

   Save

3. Severe asthma: One disease and multiple definitions

   D. Bagnasco, P. Paggiaro, M. Latorre, C. Folli +119 more

   2021The World Allergy Organization Journal34 citations Open access

   Semantic Scholar

   Save

4. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders

   D. Bagnasco, S. Nicola, Elisa Testino, L. Brussino +25 more

   2023Biomedicines21 citations Open access

   Semantic Scholar

   Save

5. Specific Therapy for T2 Asthma

   D. Bagnasco, Elisa Testino, S. Nicola, Laura Melissari +4 more

   2022Journal of Personalized Medicine20 citations Open access

   Semantic Scholar

   Save

6. The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life

   D. Bagnasco, A. Massolo, M. Bonavia, L. Brussino +17 more

   2019Allergy. European Journal of Allergy and Clinical Immunology19 citations Open access

   Semantic Scholar

   Save

7. Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment

   D. Bagnasco, E. Heffler, Elisa Testino, G. Passalacqua +1 more

   2019Expert Opinion on Drug Metabolism & Toxicology18 citations Open access

   Semantic Scholar

   Save

8. Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients

   Manuela Latorre, A. Rizzi, P. Paggiaro, I. Baiardini +36 more

   2024Journal of Asthma6 citations Open access

   Semantic Scholar

   Save

9. Background therapy in severe asthma on monoclonal antibody treatment in real life.

   Filippo F. Cosini, D. Bagnasco, F. Braido, G. Canonica +3 more

   2025Respiratory Medicine5 citations

   Semantic Scholar

   Save

10. Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy

    D. Bagnasco, L. Pini, Benedetta Bondi, Carola Montagnino +8 more

    2025Biomedicines2 citations Open access

    Semantic Scholar

    Save

11. Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma

    D. Bagnasco, M. Povero, L. Pradelli, E. Heffler +9 more

    20201 citations Open access

    Semantic Scholar

    Save

12. Enhancing airway function and resolving mucus plugs: a case study on dupilumab treatment

    D. Bagnasco, R. Picasso, Benedetta Bondi, Veronica Capuano +3 more

    2025Exploration of Asthma & Allergy0 citations Open access

    Semantic Scholar

    Save

13. The STREET (Structured Efficient E-Tracking) Project for early COPD Diagnosis and Care.

    M. Milanese, Elisa Testino, Alessandro Cavaliere, Giovanni Cavallaro +3 more

    2024General practice and primary care0 citations

    Semantic Scholar

    Save

14. Overlapping biological drugs prescription status: real life in Genoa

    D. Bagnasco, T. Aloè, Tommaso Bondavalli, Elisa Testino +2 more

    2018Clinical Problems0 citations

    Semantic Scholar

    Save

15. Allergen Immunotherapy: Current State and Ways Forward

    D. Bagnasco, M. Ferr, Elisa Testino, A. Riccio +2 more

    20180 citations

    Semantic Scholar

    Save